PeptiDream (OTCMKTS:PPTDF – Get Free Report) is expected to announce its resultson Wednesday, August 12th. Analysts expect the company to post earnings of ($0.0196) per share and revenue of $34.8960 million for the quarter.
PeptiDream Price Performance
OTCMKTS:PPTDF opened at $5.88 on Wednesday. The business has a fifty day simple moving average of $6.26 and a two-hundred day simple moving average of $7.82. PeptiDream has a 1 year low of $5.88 and a 1 year high of $12.85.
About PeptiDream
PeptiDream Inc (OTCMKTS:PPTDF) is a Tokyo-based biopharmaceutical company specializing in the discovery and development of peptide-based therapeutics. Since its founding in 2006, the company has built a proprietary Peptide Discovery Platform System (PDPS) that combines encoded peptide libraries with high-throughput screening to identify new macrocyclic and constrained peptides. These compounds are designed to bind with high specificity and affinity to challenging targets, including protein–protein interactions that are often undruggable by conventional small molecules.
The company’s core business model centers on collaborating with global pharmaceutical and biotechnology partners, granting access to its PDPS for early‐stage drug discovery programs.
Recommended Stories
- Five stocks we like better than PeptiDream
- CoreWeave Powers Up: The Asia Infrastructure Grab
- Boot Barn Stock Still Has Room to Run, But It Must Earn Its Premium
- Palantir Soars 30% After Blockbuster Earnings—Is the Rally Just Getting Started?
- Visa’s BioCatch Deal Could Make Fraud Prevention a Bigger Business
Receive News & Ratings for PeptiDream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PeptiDream and related companies with MarketBeat.com's FREE daily email newsletter.
